Design of novel antitumor DNA alkylating agents: the benzacronycine series.

Marie-Hélène David-Cordonnier; William Laine; Thomas Gaslonde; Sylvie Michel; Francois Tillequin; Michel Koch; Stéphane Léonce; Alain Pierré; Christian Bailly

doi:10.2174/1568011043482115

Design of novel antitumor DNA alkylating agents: the benzacronycine series.

Identifier:nobleid.org/w1/20260515/821D6CD3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/821D6CD3.svg?ark=w1%2F20260515%2F821D6CD3)](https://nobleid.org/work/w1/20260515/821D6CD3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Marie-Hélène David-Cordonnier

Claim authorship of this work

Design of novel antitumor DNA alkylating agents: the benzacronycine series.

Identifier:nobleid.org/w1/20260515/821D6CD3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/821D6CD3.svg?ark=w1%2F20260515%2F821D6CD3)](https://nobleid.org/work/w1/20260515/821D6CD3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Marie-Hélène David-Cordonnier

Claim authorship of this work